Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.7309 USD
−7.38 M USD
0.00 USD
1.80 M
About Channel Therapeutics Corporation
Sector
Industry
CEO
Francis P. Knuettel
Website
Headquarters
Freehold
Founded
2002
FIGI
BBG01C9YP5V5
Channel Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. The company was founded in 2002 and is headquartered in Freehold, NJ.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CHRO is 0.6435 USD — it has decreased by −1.45% in the past 24 hours. Watch Channel Therapeutics Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Channel Therapeutics Corporation stocks are traded under the ticker CHRO.
CHRO stock has fallen by −5.10% compared to the previous week, the month change is a 18.95% rise, over the last year Channel Therapeutics Corporation has showed a −89.28% decrease.
CHRO reached its all-time high on Feb 16, 2024 with the price of 6.0000 USD, and its all-time low was 0.4500 USD and was reached on Nov 19, 2024. View more price dynamics on CHRO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CHRO stock is 16.19% volatile and has beta coefficient of 2.18. Track Channel Therapeutics Corporation stock price on the chart and check out the list of the most volatile stocks — is Channel Therapeutics Corporation there?
Yes, you can track Channel Therapeutics Corporation financials in yearly and quarterly reports right on TradingView.
Channel Therapeutics Corporation is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
CHRO net income for the last quarter is −1.69 M USD, while the quarter before that showed −1.77 M USD of net income which accounts for 4.34% change. Track more Channel Therapeutics Corporation financial stats to get the full picture.
No, CHRO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 8.00 employees. See our rating of the largest employees — is Channel Therapeutics Corporation on this list?
Like other stocks, CHRO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Channel Therapeutics Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Channel Therapeutics Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Channel Therapeutics Corporation stock shows the sell signal. See more of Channel Therapeutics Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.